59 related articles for article (PubMed ID: 18334713)
1. Re: C-reactive protein and risk of breast cancer.
Zeleniuch-Jacquotte A; Gu Y; Bruning PF; Bonfrer JM; Koenig KL; Arslan AA; Toniolo P; Shore RE
J Natl Cancer Inst; 2008 Mar; 100(6):443-4; author reply 444-5. PubMed ID: 18334713
[No Abstract] [Full Text] [Related]
2. Inflammatory biomarkers and risk of lung cancer.
Lagiou P; Trichopoulos D
J Natl Cancer Inst; 2011 Jul; 103(14):1073-5. PubMed ID: 21685358
[No Abstract] [Full Text] [Related]
3. Exploring a cancer biomarker: the example of C-reactive protein.
Boffetta P
J Natl Cancer Inst; 2010 Feb; 102(3):142-3. PubMed ID: 20056953
[No Abstract] [Full Text] [Related]
4. [Gail coefficient as a risk factor and prognosticator for the course of breast cancer: correlation with hormonal and metabolic parameters and clinical and morphologic features].
Boiarkina MP; Tsyrlina EV; Poroshina TE; Semiglazov VF; Bershteĭn LM
Vopr Onkol; 2008; 54(1):25-30. PubMed ID: 18416053
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-6 and C-reactive protein in metastatic renal cell carcinoma.
Altundag O; Altundag K; Gunduz E
J Clin Oncol; 2005 Feb; 23(5):1044; author reply 1044-5. PubMed ID: 15701926
[No Abstract] [Full Text] [Related]
6. Studying inflammatory markers and their relationship with coronary risk factors in elderly egyptian people with diabetes mellitus.
Amer MS; Maher MM; Mabrouk RR; Hamza SA; Khater MS
J Am Geriatr Soc; 2008 Sep; 56(9):1762-3. PubMed ID: 19166451
[No Abstract] [Full Text] [Related]
7. The relationship between interleukin-6 and C-reactive protein in patients with benign and malignant prostate disease.
McArdle PA; McMillan DC; Sattar N; Wallace AM; Underwood MA
Br J Cancer; 2004 Nov; 91(10):1755-7. PubMed ID: 15505624
[TBL] [Abstract][Full Text] [Related]
8. Re: Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women.
Vigneri R; Frasca F; Sciacca L; Vigneri P; Frittitta L
J Natl Cancer Inst; 2009 Jul; 101(14):1030-1; author reply 1031-2. PubMed ID: 19546433
[No Abstract] [Full Text] [Related]
9. [C-reactive protein, risk of and survival after cancer--secondary publication].
Allin KH; Bojesen SE; Nordestgaard BG
Ugeskr Laeger; 2009 Nov; 171(48):3510-3. PubMed ID: 19953727
[TBL] [Abstract][Full Text] [Related]
10. Community socioeconomic status is associated with circulating interleukin-6 and C-reactive protein.
Petersen KL; Marsland AL; Flory J; Votruba-Drzal E; Muldoon MF; Manuck SB
Psychosom Med; 2008 Jul; 70(6):646-52. PubMed ID: 18606725
[TBL] [Abstract][Full Text] [Related]
11. Physical activity and postmenopausal breast cancer: proposed biologic mechanisms and areas for future research.
Neilson HK; Friedenreich CM; Brockton NT; Millikan RC
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):11-27. PubMed ID: 19124476
[TBL] [Abstract][Full Text] [Related]
12. Predictors of lymphedema in patients with breast cancer undergoing axillary lymph node dissection in Hong Kong.
Mak SS; Yeo W; Lee YM; Mo KF; Tse KY; Tse SM; Ho FP; Kwan WH
Nurs Res; 2008; 57(6):416-25. PubMed ID: 19018216
[TBL] [Abstract][Full Text] [Related]
13. Changes in body mass index are associated with changes in inflammatory and endothelial dysfunction biomarkers in obese prepubertal children after 9 months of body mass index SD score loss.
Martos R; Valle M; Morales RM; Cañete R; Gascón F; Urbano MM
Metabolism; 2009 Aug; 58(8):1153-60. PubMed ID: 19477472
[TBL] [Abstract][Full Text] [Related]
14. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
Goei D; Hoeks SE; Boersma E; Winkel TA; Dunkelgrun M; Flu WJ; Schouten O; Bax JJ; Poldermans D
Coron Artery Dis; 2009 May; 20(3):219-24. PubMed ID: 19322079
[TBL] [Abstract][Full Text] [Related]
15. C-reactive protein 1059G>C genetic polymorphism influences serum C-reactive protein levels after esophagectomy in patients with thoracic esophageal cancer.
Motoyama S; Miura M; Hinai Y; Maruyama K; Usami S; Nakatsu T; Saito H; Minamiya Y; Suzuki T; Ogawa J
J Am Coll Surg; 2009 Oct; 209(4):477-83. PubMed ID: 19801321
[TBL] [Abstract][Full Text] [Related]
16. Is high-sensitive C-reactive protein a biomarker for functional somatic symptoms? A population-based study.
Tak LM; Bakker SJ; Slaets JP; Rosmalen JG
Brain Behav Immun; 2009 Oct; 23(7):1014-9. PubMed ID: 19501644
[TBL] [Abstract][Full Text] [Related]
17. Serum insulin-like growth factor-I and platelet-derived growth factor as biomarkers of breast cancer prognosis.
Pasanisi P; Venturelli E; Morelli D; Fontana L; Secreto G; Berrino F
Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1719-22. PubMed ID: 18628423
[TBL] [Abstract][Full Text] [Related]
18. Circulating estradiol defines the tumor phenotype in menopausal breast cancer patients.
Schneider J; Martín-Gutiérrez S; Tresguerres JA; García-Velasco JA
Maturitas; 2009 Sep; 64(1):43-5. PubMed ID: 19647960
[TBL] [Abstract][Full Text] [Related]
19. Influence of preoperative inflammation on outcomes of colorectal cancer surgery.
Fujita T
Ann Surg; 2008 Jun; 247(6):1084-5; author reply 1085-6. PubMed ID: 18520251
[No Abstract] [Full Text] [Related]
20. Serum high-density lipoprotein cholesterol and breast cancer risk by menopausal status, body mass index, and hormonal receptor in Korea.
Kim Y; Park SK; Han W; Kim DH; Hong YC; Ha EH; Ahn SH; Noh DY; Kang D; Yoo KY
Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):508-15. PubMed ID: 19190159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
